首页> 外国专利> Quinoline type mevalonolactones useful for treating hyperlipidemia, hyperlipoproteinemia or atherosclerosis

Quinoline type mevalonolactones useful for treating hyperlipidemia, hyperlipoproteinemia or atherosclerosis

机译:喹啉型甲羟戊内酯可用于治疗高脂血症,高脂蛋白血症或动脉粥样硬化

摘要

A compound of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are independently hydrogen, C.sub.1-6 alkyl, C.sub.1- 6 cycloalkyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, sec-butoxy, R.sup.7 R. sup.8 N-- (wherein R.sup.7 and R.sup.8 are independently hydrogen or C. sub.1-3 alkyl), trifluoromethyl, trifluoromethoxy, difluoromethoxy, fluoro, chloro, bromo, phenyl, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-t-butylsilyloxy, hydroxymethyl or -- O(CH.sub. 2).sub.l OR.sup.19 (wherein R.sup.19 is hydrogen or C.sub.1-3 alkyl, and l is 1,2 or 3); or when located at the ortho position to each other, R. sup.1 and R.sup.2, or R.sup.3 and R.sup.4 together form -- CH═CH--CH. dbd.CH--; or when located at the ortho position to each other, R.sup.1 and R.sup.2 together form --OC(R.sup.15 l) (R.sup.16)O-- (wherein R.sup. 15 and R.sup.16 are independently hydrogen or C.sub.1-3 alkyl); Y is --CH. sub.2 --, --CH.sub.2 CH.sub.2 --, --CH═CH--, --CH. sub.2 --CH═CH-- or -- CH═CH--CH.sub.2 --; and Z is --Q--CH.sub. 2 WCH.sub.2 --CO.sub.2 R.sup.12, ##STR2## (wherein Q is --C(O)--, --C(OR. sup.13).sub.2 -- or -- CH(OH)--; W is --C(O)--, --C(OR.sup.13).sub.2 -- or --C(R.sup.11) (OH)--; R.sup.11 is hydrogen atom or C.sub.1-3 alkyl; R. sup.12 is hydrogen or R. sup.14 (wherein R.sup.14 is physiologically hydrolyzable alkyl or M (wherein M is NH.sub.4, sodium, potassium, 1/2 calcium or a hydrate of lower alkyl amine, di-lower alkyl amine or tri- lower alkyl amine)); two R. sup.13 are independently primary or secondary C.sub.1-6 alkyl; or two R. sup.13 together form --(CH.sub.2).sub.2 -- or - -(CH.sub.2).sub.3 ; R.sup. 17 and R.sup.18 are independently hydrogen or C.sub.1-3 alkyl; and R.sup. 5 is hydrogen, C.sub.1-6 alkyl, C.sub.2-3 alkenyl, C.sub.3-6 cycloalkyl, ##STR3## wherein R.sup.9 is a hydrogen atom, C.sub.1-4 alkyl, C.sub.1-3 alkoxy, fluoro, chloro, bromo or trifluoromethyl), phenyl--(CH.sub.2).sub. m -- (wherein m is 1,2 or 3), -- (CH.sub.2).sub.n CH(CH.sub.3)--phenyl or phenyl--(CH.sub.2).sub.n CH(CH. sub.3)-- (wherein n is 0,1 or 2).
机译:具有下式的化合物:其中R 1,R 2,R 3,R 4和R 6独立地是氢,C 1 -6烷基,C 1-6环烷基,C 1-3烷氧基,正丁氧基,异丁氧基,仲丁氧基,R 7 R. sup.8 N--(其中R 7和R 8独立地是氢或C 1-3烷基),三氟甲基,三氟甲氧基,二氟甲氧基,氟代,氯代,溴代,苯基,苯氧基,苄氧基,羟基,三甲基甲硅烷氧基,二苯基-丁基甲硅烷氧基,羟甲基或-O(CH 2)OR 1(其中R 19是氢或C 1-3烷基,l是1,2或3 );或位于彼此正交的位置时,R。sup.1和R.sup.2或R.sup.3和R.sup.4一起形成-CH═ CH-CH。 dbd.CH--;或位于彼此正交的位置时,R.sup.1和R.sup.2一起形成--OC(R.sup。15 l)(R.sup.16)O--(其中R.sup 15和R 16独立地是氢或C 1-3烷基); Y是-CH。 sub.2-,--CH.sub.2 CH.sub.2-,--CH═ CH--,--CH。 sub.2 --CH═ CH--或-CH═ CH--CH.sub.2-; Z是--Q--CH.sub。 2 WCH.sub.2 --CO.sub.2 R.sup.12,## STR2 ##(其中Q是--C(O)-,--C(OR.sup.13)。 2-或-CH(OH)-; W是--C(O)-,--C(OR.sup.13).sub.2-或--C(R.sup.11 )(OH)-; R.sup.11是氢原子或C.sub.1-3烷基; R.sup.12是氢或R.sup.14(其中R.sup.14是生理上可水解的烷基或M(其中M为NH4,钠,钾,1/2钙或低级烷基胺,二低级烷基胺或三低级烷基胺的水合物));两个R. sup.13独立地为伯或仲C 1-6烷基;或两个R sup 13一起形成-(CH 2)2-或-(CH 2)3;或Rs17和R1818独立地是氢或C 1-3烷基; R 5是氢,C 1-6烷基,C 2-3烯基,C 3-6环烷基,其中R 9是氢原子,C 1-4烷基,C 1-3烷氧基,氟,氯,溴或三氟甲基),苯基-(CH.sub.2).sub。 m-(其中m为1,2或3),-(CH.sub.2)n CH(CH.sub.3)-苯基或苯基-(CH.sub.2)。 sub.n CH(CH.sub.3)-(其中n是0,1或2)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号